BRISBANE, Calif., Sept. 23, 2008 (GLOBE NEWSWIRE) -- BiPar Sciences, Inc., a privately held biopharmaceutical company developing PARP inhibitors as novel cancer therapies, today announced that it has appointed Sunil Patel to vice president, Corporate Development and Marketing, and Adrienne Weil to the position of Legal Counsel.
